Cite
HARVARD Citation
Schwint, A. et al. (2015). 'Close-to-ideal' tumor boron targeting for boron neutron capture therapy is possible with 'less-than-ideal' boron carriers approved for use in humans. Therapeutic delivery. pp. 269-272. [Online].